Human-derived bacteria that induce proliferation or accumulation of regulatory T cells
US9649345B2 · kind B2 · utility
67Cited by
13References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 9, 2016 |
| Grant date | May 16, 2017 |
| Priority date | — |
| Expiry date | Feb 21, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.